Pillar Biosciences Launches Innovative NGS Panel for Tumor Profiling Pillar Biosciences has unveiled its latest oncoReveal Lymphoid NGS panel, enhancing the efficiency of tumor profiling in lymphoid malignancies.

Pillar Biosciences Launches Innovative NGS Panel for Tumor Profiling #USA #Natick #Pillar_Biosciences #oncoReveal #NGS_Technology

Pillar Biosciences Achieves Nationwide Medicare Coverage for Innovative oncoReveal® CDx Pan-Cancer Testing Pillar Biosciences, a leader in Decision Medicine™, announces receipt of CMS coverage for its FDA-approved oncoReveal® CDx kit, enhancing access for cancer patients.

Pillar Biosciences Achieves Nationwide Medicare Coverage for Innovative oncoReveal® CDx Pan-Cancer Testing #USA #Natick #Pillar_Biosciences #oncoReveal #Decision_Medicine